Terveystalo Oyj

Terveystalo Plc's Annual General Meeting decided that the Board's annual remuneration would be a mix of the company's shares and cash, with 40% in shares and 60% in cash. The shares are to be bought from the market after the quarterly results for July to September 2024 are published. As per this decision, 1,673 shares were acquired for Sofia Hasselberg, a Board member, as part of a share-based incentive. The transaction occurred on October 30, 2024, with the shares having a unit price of 0.00 EUR. Terveystalo is Finland's largest private healthcare provider and a major occupational health service provider in the Nordic region, offering a range of health services to various customers. The company operates over 377 clinics in Finland and 152 in Sweden, employing over 15,500 professionals, and is listed on the Helsinki Stock Exchange.

Terveystalo Plc's Annual General Meeting decided on March 26, 2024, to pay the Board's annual remuneration as a mix of company shares and cash, with 40% in shares and 60% in cash. The shares are to be purchased from the market within two weeks after the quarterly results for July to September 2024 are published. As part of this resolution, 1,673 shares were acquired for Teija Sarajärvi, a member of the Board, on October 30, 2024. Terveystalo is Finland's largest private healthcare provider and a leading occupational health provider in the Nordic region, with extensive services and a significant presence in Finland and Sweden. The company is listed on the Helsinki Stock Exchange and had about 1.2 million individual customers in 2023.

Terveystalo Plc has announced its financial calendar for 2025. The company will release its financial statements for 2024 on February 14, 2025, and its Annual Report during Week 11 of 2025. The interim reports for the periods ending March 31, June 30, and September 30, 2025, will be published on April 25, July 17, and October 23, 2025, respectively. These reports will be available in Finnish and English, typically around 9:00 a.m. EET. Terveystalo will observe a 30-day silent period before releasing its financial information. The Annual General Meeting is scheduled for April 8, 2025, with details to be announced later. Terveystalo is Finland's largest private healthcare provider and a leading occupational health provider in the Nordic region, offering a wide range of services through its digital platform and numerous clinics in Finland and Sweden. The company is listed on the Helsinki Stock Exchange and had around 1.2 million individual customers in Finland in 2023, with approximately 7.6 million customer appointments. Terveystalo employs over 15,500 professionals. For more information, contact Liisa-Maija Seppänen, Investor Relations Manager.

Terveystalo Plc announced the appointment of Petteri Lankinen as Chief Medical Officer and member of the Executive Team, effective by January 25, 2025. Dr. Lankinen, who holds a Doctor of Medical Science degree and an eMBA, will report to CEO Ville Iho. He joins Terveystalo from his role as Chief Medical Officer and Senior Partner at Nordic Healthcare Group. Dr. Lankinen's previous roles include Managing Director of Specialized Health Care and Hospital Services in Satakunta and Chief Medical Officer at Satakunta Hospital District and Turku University Hospital. CEO Ville Iho highlighted Dr. Lankinen's expertise in specialized medical care and leadership in orthopaedics. Terveystalo is Finland's largest private healthcare provider and a leading occupational health provider in the Nordic region, with extensive services and a significant network of clinics in Finland and Sweden.

Terveystalo's Interim Report for January–September 2024 highlights strong earnings growth and improved profitability. Revenue for the third quarter increased by 5% to EUR 296 million, with adjusted EBITA rising by over 62% to EUR 34 million. Earnings per share quadrupled to EUR 0.12. The Healthcare services segment showed a 11% revenue growth, reaching EUR 232 million, driven by a strong supply, improved sales mix, and a strong flu season. Despite a 10% revenue drop, Portfolio businesses saw a 70% increase in adjusted EBITA to EUR 3 million. The Swedish business faced a 10% revenue decline due to expired contracts and weakened demand. Terveystalo expects its full-year 2024 revenue to grow, with adjusted EBITA projected to be 12.0–12.5% of revenue. The company has adjusted its cost structure and aims for a profitability turnaround in Sweden by 2025. Terveystalo will discuss its future strategy at the December Capital Markets Day. The company remains focused on profitable growth and high medical quality.

Terveystalo Plc announced the composition of its Shareholders' Nomination Board, which includes representatives from the four largest shareholders as of 2 September 2024 and the Chairman of the Board of Directors. The members are Risto Murto (Varma Mutual Pension Insurance Company), Tomas von Rettig (Rettig Group AB), Timo Ritakallio (Pohjola Insurance Ltd and OP Life Assurance Company Ltd), and Kari Kauniskangas (Chairman of the Board of Directors of Terveystalo Plc). Risto Murto was elected as Chairman of the Nomination Board during its organizing meeting on 27 September 2024. The Nomination Board is responsible for searching, preparing, and presenting member candidates for the Board of Directors and handling matters related to board remuneration. Proposals for the Annual General Meeting will be forwarded to Terveystalo's Board of Directors by 1 February 2025. Further details are available on Terveystalo's website. Terveystalo is the largest private healthcare service provider in Finland and a leading occupational health provider in the Nordic region, offering a wide range of healthcare services through its digital platform and numerous clinics in Finland and Sweden. The company is listed on the Helsinki Stock Exchange and employs over 15,500 professionals.